Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
AssigneeEMD Lexigen Research Center Corp.
InventorsStephen D. Gillies, Kin Ming Lo, John S. Wesolowski, Jr.
Life of this patent
Estimating the term…
Loading patent…
AssigneeEMD Lexigen Research Center Corp.
InventorsStephen D. Gillies, Kin Ming Lo, John S. Wesolowski, Jr.
Estimating the term…
Disclosed herein are methods and compositions for enhancing the immunogenicity of a preselected protein or peptide antigen in a mammal. Immunogenicity is enhanced by fusing the preselected antigen to an immunoglobulin heavy chain constant region to produce an Fc-antigen fusion protein. The Fc-antigen fusion proteins bind Fc receptors on the surface of antigen presenting cells, thereby targeting the antigen to the antigen presenting cells in the mammal. In addition, disclosed is a family of adjuvants, for example, an Fc-adjuvant fusion protein, for use in combination with the Fc-antigen fusion proteins to enhance or modulate a particular immune response against the preselected antigen.
A method for eliciting an immune response against an antigen in a mammal, the method comprising:
A composition for eliciting an immune response against an antigen in a mammal, the composition comprising:
Dependencies are inferred from the claim text.